ExoVasc® PEARS

ExoVasc® Implant

Proven innovation in cardiovascular care through personalised vessel support to prevent dilatation and dissection.

About ExoVasc®

The ExoVasc® implant is a personalised external support designed to reinforce the body’s major blood vessels to prevent dilatation and dissection, offering a safe and lasting alternative to major surgery.

A Growing Network of Expertise

Now in use at more than 40 leading cardiac centres across the UK, Europe, Australia and beyond. ExoVasc® continues to deliver excellent results.

* Currently unavailable in the USA

Real Experiences

Over 1,600 people worldwide have benefitted from an ExoVasc implant. Their stories highlight the day-to-day realities of living with an aortic condition and the personal perspectives that shape their experiences.

Built from Experience

Exstent was founded by engineer Tal Golesworthy, who, as a patient with Marfan syndrome, developed the ExoVasc® device as a personalised alternative to aortic root replacement and lifelong anticoagulation.

Today, Exstent continues to advance patient-centred innovation through the ExoVasc® implant, expanding access through clinical collaboration and strategic partnerships.

0 +
ExoVasc® Procedures Since 2004
0
Years of Data
0 +
Centres Worldwide

Patient stories

Real experiences from real people

"I was highly motivated to recover from the very start, so I was already walking laps around the ward while still in the hospital. At home, I also began exercising on a stationary bike right away, starting with very short, light sessions. Just as with walking, I initially struggled with shortness of breath, so I would take a break after a few minutes; however, things improved quickly. In fact, I felt better each day than the day before. "
My name is Walter; I am 72 years old. I live in the Netherlands and work as a musician and photographer. I underwent a PEARS procedure on May 27, 2026, at the AMC hospital in Amsterdam, performed by Dr. Dave Koolbergen. Now, more than three months after that operation, I am writing this account out of gratitude for the...

Walter

Date of procedure: 2026 | Age: 72

Latest News & Updates

Updates for patients, clinicians and partners.

Tal Golesworthy brings the ExoVasc® story to BioMedEng26

From patient to pioneer: Tal Golesworthy tells the story behind ExoVasc® on BBC World Service

Investing in the Future of Aortic Care

Discover how Exstent is scaling a proven technology through collaboration and investment.